Bernard A. Feigenbaum, MD

Bernard A. Feigenbaum, M.D. attended the Boston University 6-year accelerated medical program and received his B.A. and M.D. in 1989. He is a Voluntary Assistant Clinical Professor at UCSD School of Medicine, and was formerly on the clinical faculty at Yale University School of Medicine and NYU School of Medicine. He is Board-Certified, and has over 30 years of clinical and teaching experience as an adult and pediatric Allergy & Immunology specialist.

He has experience with a wide range of conditions including eczema/dermatitis, food allergy, allergic nasal and sinus issues, asthma, vocal cord dysfunction, drug reactions as well as a wide range of allergy testing and procedures in the clinic and hospital.

Dr. Feigenbaum is passionate about providing evidence-based Allergy & Immunology medical care with the goal of identifying root causes and minimizing the need for medication. He is known for his friendly, caring manner, professionalism, and his teaching and communication.

He recently moved from San Diego and loves exploring SF and the Marin Headlands and jamming on his acoustic.

Education and Training

Education
1989 MD Boston University School of Medicine (Accelerated 6 Year Medical Program. Combined BA/MD 1983 to 1989)

Residency & Fellowship
1989-1992 Internal Medicine Intern and Resident, (Scripps) Mercy Hospital
1992-1993 Chief Resident, (Scripps) Mercy Hospital
1993-1995 Clinical Fellow in Allergy & Immunology, Scripps Clinic

Publications

  • Lieberman SM, Jacobs JB, Lebowitz RA, Fitzgerald MB, Crawford J, Feigenbaum BA.Measurement of
    Mycotoxins in Patients with Chronic Rhinosinusitis. Otolaryngol Head Neck Surg, 2011;145(2): 327–29
  • Romanos-Sirakis, E, Feigenbaum BA. Immediate Hypersensitivity Reaction and Successful Rapid Desensitization
    to Rituximab Followed by Serum Sickness in a 4 Year Old. (Abstract) J Allergy Clin Immunol, 2011; 127: Supp,
    AB198.
  • Mathew A, Ballas M, Gorsky M, Miro K, Feigenbaum BA. Rapid Desensitization Does Not Prevent
    “Idiosyncratic” Reaction with Fever to Oxaliplatin. (Abstract) J Allergy Clin Immunol, 2011; 127: Supplement,
    AB195.
  • Sutaria M, Miro K, Kister I, Herbert J, Mathew A, Feigenbaum BA. Special Considerations for Rapid Drug
    Desensitization with Natalizumab. (Abstract) J Allergy Clin Immunol, 2011; 127:Supp, AB196.
  • Mathew A, Feigenbaum BA, Miro K, Weinfeld JN. Iatrogenic Hypogammaglobulinemia Resembling Common
    Variable Immunodeficiency. (Abstract) Ann Allergy Asthma Immunol 2010; 105; A101.
  • Miro K, Feigenbaum BA, Mathew A, Weinfeld JN. Successful Oxaliplatin Desensitization After Unsuccessful
    Infusion Using A Hypersensitivity Protocol. (Abstract) Ann Allergy Asthma Immunol 2010; 105; A27.
  • Feigenbaum BA. Fractional exhaled nitric oxide in subjects with atopic asthma: Correct Definitions
    of the Terms Atopy and Asthma. (Correspondence) Ann Allergy Asthma Immunol 2008; 101; 110.
  • Feigenbaum BA, Simon RA. Remission of Steroid Dependent Asthma Following Fundoplication for
    Asymptomatic Reflux. J Allergy Clin Immunol, 1995; 95:202.
  • Feigenbaum BA. Insect-sting challenges-all risk and no benefit? (Letter) J Allergy Clin Immunol 1995;
    96:704-705.
  • Feigenbaum BA, Stevenson DD, Simon RA. Hydrocortisone Sodium Succinate Does Not Cross-react
    With Aspirin in Aspirin Sensitive Asthmatics. J Allergy Clin Immunol 1995; 96:545-8.
  • Feigenbaum BA, Simon RA. A Case of Vocal Cord Dysfunction Mimicking Asthma. Ann Allergy, 1995; 74:92.
  • Feigenbaum BA, Stevenson DD, Simon RA. Respiratory Succinate Sensitivity That Does Not Cross-react
    In An Aspirin Sensitive Asthmatic. Ann Allergy, 1994; 72:94.
  • Feigenbaum BA, Simon RA, Stevenson DD. Aspirin Intolerance. (Letter) Ann Allergy, 1994; 73:455-56.
  • Feigenbaum BA, Stevenson DD, Simon RA. Lack of Cross-Sensitivity To IV Hydrocortisone in
    Aspirin-Sensitive Subjects With Asthma. J Allergy Clin Immunol 1994; 93:242.

Locations